Skip to main content
. 2024 Jul 10;2024:8752787. doi: 10.1155/2024/8752787

Table 1.

Summary for the skin biophysical and clinical assessments.

Timepoint Placebo mean ± SD n p value change from baseline AC treatment mean ±SD n p value change from baseline p value treatment vs. placebo
Confocal fragmentation
 Week 0 5.66 ± 1.32 52 5.81 ± 1.0 48
 Week 6 5.62 ± 1.27 51 p=0.82 4.34 ± 1.19 47 p < 0.01 p < 0.01
 Week 12 5.65 ± 1.21 48 p=0.98 3.22 ± 1.24 46 p < 0.01 p < 0.01
Ultrasound HEP pixel count
 Week 0 280.1 ± 380.2 52 303.5 ± 351.0 45
 Week 6 984.8 ± 712.8 49 p < 0.01 1135.4 ± 804.5 44 p < 0.01 p=0.46
 Week 12 772.3 ± 545.9 51 p < 0.01 1005.0 ± 765.5 47 p < 0.01 p=0.06
Ultrasound LEP ratio
 Week 0 1.07 ± 0.21 52 0.95 ± 0.26 46
 Week 6 0.97 ± 0.19 49 p < 0.01 0.79 ± 0.19 44 p < 0.01 p < 0.01
 Week 12 0.99 ± 0.22 51 p=0.05 0.86 ± 0.24 47 p=0.04 p=0.05
Corneometer hydration
 Week 0 52.9 ± 15.8 52 59.9 ± 13.7 48
 Week 6 51.1 ± 11.8 52 p=0.26 64.4 ± 10.9 48 p < 0.01 p < 0.01
 Week 12 45.3 ± 11.0 52 p < 0.01 68.2 ± 12.5 48 p < 0.01 p < 0.01
Elasticity R2
 Week 0 0.668 ± 0.08 52 0.682 ± 0.10 48
 Week 6 0.683 ± 0.09 52 p=0.215 0.823 ± 0.09 48 p < 0.01 p < 0.01
 Week 12 0.682 ± 0.09 52 P=0.254 0.837 ± 0.11 48 p < 0.01 p < 0.01
Profilometry Rz
 Week 0 139.0 ± 10.6 52 136.9 ± 11.0 48
 Week 6 140.7 ± 10.8 52 p=0.25 126.3 ± 9.9 48 p < 0.01 p < 0.01
 Week 12 144.1 ± 11.1 52 p < 0.01 110.1 ± 8.4 48 p < 0.01 p < 0.01
Glogau Scale
 Week 0 2.56 ± 0.67 52 2.56 ± 0.65 48
 Week 6 2.56 ± 0.67 52 n.c 2.50 ± 0.62 48 p=0.08 p=0.07
 Week 12 2.56 ± 0.69 52 n.c 2.34 ± 0.64 48 p < 0.01 p < 0.01
Skin even tone
 Week 0 5.46 ± 1.29 52 5.60 ± 1.12 48
 Week 6 5.37 ± 1.25 52 p=0.3 4.58 ± 1.09 48 p < 0.01 p < 0.01
 Week 12 5.21 ± 1.26 52 p < 0.01 3.81 ± 1.08 48 p < 0.01 p < 0.01

Descriptive and probability statistics for the skin biophysical parameters and expert visual grading scales are presented. The table shows the mean and standard deviation for each measurement, with statistical significance for change from baseline, and for treatment vs placebo (at Week 6 and at Week 12). A threshold of p ≤ 0.05 was applied in all cases.